FDA — authorised 19 February 2016
- Application: ANDA204841
- Marketing authorisation holder: LANNETT CO INC
- Local brand name: SUMATRIPTAN
- Indication: SPRAY — NASAL
- Status: approved
🇺🇸 Imigran in United States
FDA authorised Imigran on 19 February 2016
Marketing authorisations
FDA — authorised 21 September 2020
- Application: ANDA213465
- Marketing authorisation holder: PADAGIS ISRAEL
- Local brand name: SUMATRIPTAN
- Indication: SPRAY — NASAL
- Status: approved
FDA — authorised 21 September 2020
- Application: ANDA213650
- Marketing authorisation holder: PERRIGO UK FINCO
- Local brand name: SUMATRIPTAN
- Indication: SPRAY — NASAL
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Imigran approved in United States?
Yes. FDA authorised it on 19 February 2016; FDA authorised it on 21 September 2020; FDA authorised it on 21 September 2020.
Who is the marketing authorisation holder for Imigran in United States?
LANNETT CO INC holds the US marketing authorisation.